Creative Planning Amarin Corp Plcuk Call Options Transaction History

Creative Planning

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 30, 2021	SELL	$5.03 - $8.8 $63,881 - $111,760	-12,700 Reduced 97.69%	300 $1,000
Q4 2020 Jan 29, 2021	BUY	$4.04 - $5.31 $12,120 - $15,929	3,000 Added 30.0%	13,000 $7,000
Q3 2020 Nov 05, 2020	BUY	$3.64 - $7.76 $20,020 - $42,680	5,500 Added 122.22%	10,000 $5,000
Q2 2020 Jul 23, 2020	SELL	$4.78 - $8.26 $478 - $826	-100 Reduced 2.17%	4,500 $3,000
Q1 2020 May 05, 2020	SELL	$4.0 - $21.53 $345,600 - $1.86 Million	-86,400 Reduced 94.95%	4,600 $1,000
Q4 2019 Jan 30, 2020	BUY	$13.94 - $24.12 $989,740 - $1.71 Million	71,000 Added 355.0%	91,000 $758,000
Q3 2019 Nov 01, 2019	BUY	$13.89 - $23.16 $138,900 - $231,600	10,000 Added 100.0%	20,000 $46,000
Q2 2019 Jul 26, 2019	SELL	$16.27 - $20.51 $162,700 - $205,100	-10,000 Reduced 50.0%	10,000 $64,000
Q1 2019 Apr 24, 2019	BUY	$12.61 - $22.33 $252,200 - $446,599	20,000 New	20,000 $89,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.